30th Oct 2009 15:41
GW Pharmaceuticals PLC
("GW")
In conformity with DTR 5.6.1R, GW hereby provides notification of the following information:
GW's issued share capital consists of 129,295,055 ordinary shares of 0.1p each with voting rights. Therefore, the total number of voting rights in GW is 129,295,055.
The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, GW under the FSA's Disclosure and Transparency Rules.
For further information, please contact:
|
GW Pharmaceuticals PLC |
+44 (0)1980 557 000 |
|
Adam George, Company Secretary |
|
|
Nominated Adviser |
+44 (0) 207 597 5970 |
|
Patrick Robb, Investec Bank plc |
Related Shares:
GWP.L